Structure-based design of inhibitors of PimA - a new target for tuberculosis therapy [ 2013 - 2016 ]

Research Grant

Researchers: Prof Martin Scanlon (Principal investigator) ,  A/Pr Keith Stubbs ,  Dr David Chalmers ,  Dr Jamie Simpson ,  Dr Paul Crellin
View all 6 related researchers

Brief description Tuberculosis (TB) is a devastating disease that kills 2 million people worldwide each year and affects one-third of the entire human population. Bacterial resistance to existing antibiotics is an ever increasing problem, highlighting the need to develop new anti-TB drugs. The aim of this project is to develop specific inhibitors to target a protein that is essential for the survival of the tuberculosis bacterium.

Funding Amount $AUD 666,246.70

Funding Scheme Project Grants

Notes Standard Project Grant